Steven Rimar, MD
Vascular Surgery · Grosse Pointe, MINPI 1205818994
Payments from drug & device makers
Across 55 payments — averaging $88.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Silk Road Medical, Inc.$961
- Bard Peripheral Vascular, Inc.$906
- Stryker$685
- Medtronic$344
- Endologix LLC$125
- plus $276 from 6 others
What the payments were for
- Travel & lodging$2,63054%
- Food & beverage$2,21546%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 25 | $1,548 |
| Silk Road Medical, Inc. | 7 | $961 |
| Bard Peripheral Vascular, Inc. | 5 | $906 |
| Stryker | 3 | $685 |
| Medtronic(2 entities) | 6 | $344 |
| Endologix LLC | 2 | $125 |
| Terumo Medical Corporation | 1 | $89 |
| Cook Medical LLC | 2 | $67 |
| Johnson & Johnson | 1 | $54 |
| Philips North America LLC | 1 | $32 |
| Boston Scientific | 1 | $19 |
| Bolton Medical Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$859
- ENROUTE Transcarotid Neuroprotection System$803
- ENROUTE Transcarotid Stent System$803
- ENHANCE Transcarotid Peripheral Access Kit$803
- ENROUTE 0.014 Guidewire$803
- FLOWTRIEVER CATHETER, S$663
- CT THROMBECTOMY SYSTEM KIT$663
- Endurant$165
- GORE TAG Thoracic Branch Endoprosthesis$142
- Conformable TAG Thoracic Endoprosthesis$115
How this compares
$4,844 in reported general payments places this provider in the 50th percentile of 183 vascular surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 82 | $2,902 |
| ClopidogrelClopidogrel Bisulfate | 42 | $570 |
| Atorvastatin Calcium | 28 | $215 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Grosse Pointe
- Nicolas MouawadWest Branch$2.6M
- Enrique Criado PallaresMidland$800K
- Vikram KashyapGrand Rapids$421K
- Andrea ObiAnn Arbor$404K
- Jordan KnepperEast Lansing$386K
- Chandu VemuriAnn Arbor$346K
- Eanas YassaGrand Rapids$185K
- Loay KabbaniDetroit$176K
- Judith LinDetroit$98K
- Joseph CuppariClinton Township$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.